Dear Editor, the publication on "How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?" is very interesting. Wei et al. noted that "*It is important that oncologists discern whether their patients are at risk of COVID-19 exposure, but it is more challenging to balance the relationship between treating tumors and preventing viruses.* [@b0005]." We would like to share ideas and experiences on radiotherapy and COVID-19 issue. We agree that radiotherapy might have some health effects in patients with COVID-19. In our country, Thailand, the second country chronological order of COVID-19 pandemic [@b0010], there are 2369 COVID-19 cases at present (8th March 2020). Of those cases, there is only 1 patient who had radiotherapy. This female patient got standard antiviral therapy and isolated respiratory care and got full recovery. We agree that it is necessary to consider benefit versus risk in using radiotherapy in the COVID-19 crisis. Nevertheless, we should not fear to use radiotherapy when there is indication.
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